VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
FAFFirst American Financial Corporation
$67.06$6.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksFAFFinancials

First American Financial Corporation (FAF) Financials

19Y historyFree accessUpdated daily

Underwriting profitability remains highly cyclical, with the combined ratio fluctuating from a peak of 110.3% in 2024Q3 to 86.0% by 2025Q4, indicating significant sensitivity to episodic loss events.

FAF Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07
Revenue6.01B7.45B6.12B6B7.59B9.21B7.08B6.2B5.75B5.77B5.58B5.18B4.68B4.96B4.54B3.82B3.91B4.05B4.37B6.08B
Revenue Growth %-4.22%21.64%2.04%-21.02%-17.58%30.14%14.21%7.9%-0.41%3.46%7.74%10.64%-5.61%9.12%18.88%-2.2%-3.46%-7.35%-28.12%-
Medical Costs & Claims1.55B326.6M2.36B2.29B3.32B3.58B2.76B2.32B2.25B2.31B2.29B2.15B1.92B2.17B1.77B1.62B1.54B346.71M509.56M875.86M
Medical Cost Ratio %25.74%4.39%38.63%38.15%43.66%38.8%39.04%37.43%39.21%40.11%41.07%41.5%41.09%43.74%38.93%42.28%39.5%8.57%11.67%14.41%
Gross Profit4.47B7.12B3.76B3.71B4.28B5.64B4.32B3.88B3.49B3.45B3.29B3.03B2.76B2.79B2.77B2.21B2.36B3.7B3.86B5.2B
Gross Margin %74.26%95.61%61.37%61.85%56.34%61.2%60.96%62.57%60.79%59.89%58.93%58.5%58.91%56.26%61.07%57.72%60.5%91.43%88.33%85.59%
Gross Profit Growth %-89.52%1.25%-13.29%-24.13%30.64%11.27%11.06%1.1%5.15%8.52%9.86%-1.16%0.51%25.79%-6.7%-36.12%-4.1%-25.81%-
Operating Expenses3.57B6.29B3.59B3.44B3.95B4B3.39B2.97B2.88B3.01B2.81B2.59B2.41B2.48B2.31B2.07B2.15B3.5B3.97B5.41B
OpEx / Revenue %59.43%84.52%58.66%57.27%52.05%43.38%47.92%47.98%50.18%52.17%50.36%50.14%51.42%49.99%50.78%54.31%55.07%86.38%90.99%89.02%
Depreciation & Amortization218.3M216.2M207.4M188.5M167.5M158.4M149M129M125.93M128.05M99.05M85.6M85.6M74.92M74.95M76.89M80.64M82.47M95.24M94.82M
Combined Ratio %85.18%88.9%97.3%95.43%95.71%82.19%86.96%85.4%89.39%92.28%91.43%91.64%92.51%93.73%89.71%96.59%94.57%94.95%102.65%103.44%
Operating Income891.4M826.2M165.4M274.4M325.7M1.64B923M905M609.54M445.33M477.58M432.76M350.56M310.71M467.41M130.29M212.11M204.34M-115.92M-208.83M
Operating Margin %14.82%11.1%2.7%4.57%4.29%17.81%13.04%14.6%10.61%7.72%8.57%8.36%7.49%6.27%10.29%3.41%5.43%5.05%-2.65%-3.44%
Operating Income Growth %-399.52%-39.72%-15.75%-80.16%77.82%1.99%48.47%36.87%-6.75%10.36%23.45%12.83%-33.52%258.73%-38.57%3.8%276.29%44.49%-
EBITDA1.11B1.04B372.8M462.9M493.2M1.8B1.07B1.03B735.47M573.38M576.63M518.36M436.16M385.62M542.36M207.18M292.75M286.82M-20.67M-114.02M
EBITDA Margin %18.45%14%6.09%7.72%6.49%19.53%15.14%16.68%12.8%9.94%10.34%10.02%9.32%7.78%11.94%5.42%7.49%7.09%-0.47%-1.88%
Interest Expense163.7M157M149.6M132.5M93M72.4M57M48M40.98M35.99M32.21M29.11M19.25M15.3M9.07M12.06M14.88M19.82M27.21M42.61M
Non-Operating Income-163.7M-157M-149.6M-132.5M-93M-72.4M-57M-48M-40.98M-35.99M-32.21M-29.11M-19.25M-15.3M-9.07M-12.06M-14.88M-19.82M-27.21M-42.61M
Pretax Income891.4M826.2M165.4M274.4M325.7M1.64B923M905M609.54M445.33M477.58M432.76M350.56M310.71M467.41M130.29M212.11M204.34M-115.92M-208.83M
Pretax Margin %14.82%11.1%2.7%4.57%4.29%17.81%13.04%14.6%10.61%7.72%8.57%8.36%7.49%6.27%10.29%3.41%5.43%5.05%-2.65%-3.44%
Income Tax216.2M201M32.8M58.9M60.4M392.2M223M195M133.64M23.47M134.1M143.9M116.34M123.64M165.68M51.71M83.15M70.07M-43.43M-86.39M
Effective Tax Rate %24.25%24.33%19.83%21.47%18.54%23.9%24.16%21.55%21.92%5.27%28.08%33.25%33.19%39.79%35.45%39.69%39.2%34.29%37.47%41.37%
Net Income672.7M621.8M131.1M216.8M263M1.24B696M707M474.5M423.05M342.99M288.09M233.53M186.37M301.04M78.28M127.83M122.39M-84M-142.98M
Net Margin %11.19%8.35%2.14%3.61%3.46%13.47%9.83%11.41%8.26%7.33%6.15%5.57%4.99%3.76%6.63%2.05%3.27%3.02%-1.92%-2.35%
Net Income Growth %324.15%374.29%-39.53%-17.57%-78.81%78.32%-1.56%49%12.16%23.34%19.06%23.36%25.31%-38.09%284.59%-38.77%4.44%245.69%41.25%-
EPS (Diluted)6.516.001.262.072.4511.146.166.224.193.763.092.622.151.712.770.731.201.18-0.81-1.37
EPS Growth %330.46%376.19%-39.13%-15.51%-78.01%80.84%-0.96%48.45%11.44%21.68%17.94%21.86%25.73%-38.27%279.45%-39.17%1.69%245.68%40.88%-
EPS (Basic)-6.021.262.082.4611.186.186.264.213.793.102.652.181.742.830.741.221.18-0.81-1.37
Diluted Shares Outstanding103.3M103.7M104.3M104.6M107.3M111.4M113.02M113.66M113.28M112.44M111.16M109.83M108.69M109.1M108.54M106.91M106.18M104.01M104.01M104.01M

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Mortgage origination volume volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Cyclical Revenue Volatility Remains Elevated

As reported in recent financial filings, First American Financial experienced a sharp 90.9% revenue contraction in 2026Q1, highlighting the extreme sensitivity of the firm's top-line performance to the prevailing mortgage origination environment and the ongoing lock-in effect impacting residential real estate transaction volumes across the United States.

The dramatic revenue swing in the most recent quarter suggests that the company's reliance on transactional volume remains a significant vulnerability. Investors should monitor whether the firm can sustain its market position during periods of low refinance activity, as the current trajectory appears heavily dependent on external macroeconomic factors rather than internal growth initiatives.

Underwriting Profitability Shows Cyclical Resilience

Based on the provided income statement data, the combined ratio fluctuated significantly, reaching a peak of 110.3% in 2024Q3 before improving to 86.0% by 2025Q4, which indicates that underwriting profitability is highly susceptible to episodic loss events and the broader housing market cycle.

The volatility in the combined ratio suggests that the company struggles to maintain consistent underwriting margins during periods of market stress. While the recent improvement to 86.0% is encouraging, it warrants further investigation into whether this reflects sustainable operational efficiency or merely a temporary reduction in claims frequency.

Operating Leverage Constrained by Fixed Costs

According to the historical data, the company's operating income has demonstrated extreme sensitivity to revenue fluctuations, with operating margins appearing to compress rapidly when transaction volumes decline, as evidenced by the negative operating income reported during the 2024Q3 period of market contraction.

The high fixed cost base associated with maintaining proprietary title plants appears to limit the company's ability to scale expenses downward during downturns. This structural reality suggests that management's efforts to integrate digital platforms like Endpoint are critical for achieving long-term operating leverage and reducing the firm's sensitivity to cyclical volume drops.

Earnings Quality Masked by Reserve Volatility

As indicated by the quarterly loss ratio data, which ranged from 4.1% to 54.3% over the last ten quarters, the company's net income appears to be significantly influenced by actuarial adjustments that may obscure the underlying core performance of the title insurance business.

The wide variance in loss ratios suggests that investors should be cautious about relying on headline net income as a proxy for operational health. It is possible that prior-year reserve releases or adjustments are smoothing earnings, which warrants further investigation into the long-term adequacy of the company's loss reserves.

FAF — Frequently Asked Questions

Quick answers to the most common questions about buying FAF stock.

What was First American Financial Corporation's (FAF) revenue in 2025?

For fiscal year 2025, First American Financial Corporation (FAF) reported total revenue of $7.45B. This represents a 22.5% increase compared to $6.08B in 2007.

Is First American Financial Corporation (FAF) profitable?

First American Financial Corporation (FAF) is profitable, generating $621.8M in net income for the fiscal year ending 2025 with a net profit margin of 8.4%.

What is First American Financial Corporation's operating profit margin?

First American Financial Corporation (FAF) reported an operating income of $826.2M, resulting in an operating profit margin of 11.1%. This margin reflects the operational efficiency of the business before interest and taxes.

What is First American Financial Corporation's gross profit and gross margin?

First American Financial Corporation (FAF) generated $7.12B in gross profit for the year, representing a gross profit margin of 95.6%. This demonstrates the company's core pricing power and production efficiency.